A detailed history of Cynosure Management, LLC transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Cynosure Management, LLC holds 3,259 shares of LNTH stock, worth $290,996. This represents 0.05% of its overall portfolio holdings.

Number of Shares
3,259
Previous 4,546 28.31%
Holding current value
$290,996
Previous $364,000 1.92%
% of portfolio
0.05%
Previous 0.06%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$77.7 - $123.62 $99,999 - $159,098
-1,287 Reduced 28.31%
3,259 $357,000
Q2 2024

Aug 13, 2024

SELL
$58.87 - $83.05 $45,624 - $64,363
-775 Reduced 14.56%
4,546 $364,000
Q1 2024

May 10, 2024

BUY
$51.07 - $68.26 $271,743 - $363,211
5,321 New
5,321 $331,000

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6.14B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Cynosure Management, LLC Portfolio

Follow Cynosure Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cynosure Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cynosure Management, LLC with notifications on news.